Related Experiment Videos
Meningeal melanocytoma.
Donncha F O'Brien1, Daniel Crooks, Conor Mallucci
1Department of Neurosurgery, Royal Liverpool Children's Hospital NHS Trust Alder Hey and the Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool, UK. dfobstl@hotmail.com
Summary
Meningeal melanocytoma, a tumor from melanocytes, often presents variably and can transform into malignant melanoma. Subtotal resection without adjuvant therapy leads to poor survival, questioning its benign classification.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Pathology
Background:
- Meningeal melanocytoma, a rare tumor originating from melanocytes, was first described over 30 years ago.
- While classified as benign, it exhibits variable presentation and a tendency for malignant transformation.
- Incomplete resection is associated with significantly reduced survival rates.
Observation:
- A fatal case of meningeal melanocytoma in a 10-year-old child is presented.
- The lesion was located in the cerebello-pontine angle.
- Angiography showed minimal vascular blush, yet the lesion was highly vascular.
Findings:
- Subtotal resection of meningeal melanocytoma without adjuvant radiotherapy yields a poor 5-year survival rate of 42%.
- The tumor's potential for malignant transformation and aggressive behavior challenges its benign classification.
- Close follow-up and adjuvant treatment are crucial after subtotal resection.
Implications:
- The classification of meningeal melanocytoma may require revision based on survival data.
- This case underscores the importance of aggressive management strategies, including adjuvant therapy and vigilant monitoring.
- Further research is needed to optimize treatment protocols for meningeal melanocytoma.